NotesFAQContact Us
Search Tips
Peer reviewed Peer reviewed
Direct linkDirect link
ERIC Number: EJ942523
Record Type: Journal
Publication Date: 2011-Sep
Pages: 7
Abstractor: As Provided
Reference Count: 14
ISSN: ISSN-2154-1647
Placebo Medication Use for Behavior Management in an Adult with Autism
Kroeger, K. A.; Brown, Jennifer
Education and Training in Autism and Developmental Disabilities, v46 n3 p470-476 Sep 2011
Buspar (buspirone) is an anxiolytic medication used to reduce symptoms associated with anxiety. The current study provides a case description of a man diagnosed with autistic disorder where Buspar was prescribed on an "as needed" basis in order to decelerate tantrum behavior associated with undifferentiated anxiety. After successful reduction of tantrum behavior over time, caregivers reported a routine drug-effect time of less than 5 minutes. With consent through the individual's employer's governing human rights committee, a placebo pill was administered in place of the Buspar in the man's work environment. The placebo has successfully maintained reduction of the tantrum behavior. Given that the experimental treatment is less restrictive on the individual than the previous treatment, a treatment reversal was deemed unethical. Theories of mechanism and maintenance are discussed, as well as limitations to the current study. Directions for future research and implications for adults with autism are also reviewed. (Contains 2 figures.)
Division on Autism and Developmental Disabilities, Council for Exceptional Children. DDD, P.O. Box 3512, Fayetteville, AR 72702. Tel: 479-575-3326; Fax: 479-575-6676; Web site:
Publication Type: Journal Articles; Reports - Evaluative; Reports - Research
Education Level: N/A
Audience: N/A
Language: English
Sponsor: N/A
Authoring Institution: N/A